Role Reversal
June 10, 2020
UC breast cancer surgeon Beth Shaughnessy learns firsthand what it’s like to overcome cancer and keeps kindness and positivity at the center of her healing
June 10, 2020
UC breast cancer surgeon Beth Shaughnessy learns firsthand what it’s like to overcome cancer and keeps kindness and positivity at the center of her healing
March 28, 2023
Researchers led by the University of Cincinnati's Nalinikanth Kotagiri, PhD, have published new research showing proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
April 14, 2023
Physics World highlighted research led by the University of Cincinnati's Nalinikanth Kotagiri that shows a proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
October 19, 2023
The University of Cincinnati’s Timothy Phoenix is one of the investigators on a research team that is part of a new NCI Pediatric Immunotherapy Network and studying how to improve immunotherapy treatments for pediatric brain tumors.
August 28, 2023
A published study by researchers at the University of Cincinnati Cancer Center and Cincinnati Children’s Hospital Medical Center shows that multiple beams and intervals in delivery during FLASH proton therapy treatment reduced skin-saving effects in preclinical models.
March 24, 2022
The University of Cincinnati is enrolling patients for a new clinical trial testing a two-pronged immunotherapy approach to treat glioblastomas, deadly brain tumors.
April 11, 2024
The University of Cincinnati Cancer Center is one of 25 sites across the country hosting the SHIP trial testing whether samples self-collected by patients for HPV testing are as accurate and effective as clinic-collected samples.
March 29, 2022
CureToday highlighted the University of Cincinnati's new glioblastoma immunotherapy trial in a recent article.
December 7, 2021
The University of Cincinnati's Dr. Vladimir Bogdanov has been awarded a Catalyst Research Award to further investigate if a drug he and his team developed is effective in treating pancreatic cancer.
June 9, 2022
Dermatology Times featured recent research by University of Cincinnati researchers that showed a low recurrence rate of nail squamous cell carcinoma when treated with surgical approaches other than amputation.